144 related articles for article (PubMed ID: 11079284)
41. [Treatment of acute attack of migraine with sumatriptan].
González-Espinosa LE; Gómez-Viera N; Olivera-Leal I; Reyes-Lorente R
Rev Neurol; 1997 Nov; 25(147):1672-5. PubMed ID: 9484515
[TBL] [Abstract][Full Text] [Related]
42. The cost effectiveness of stratified care in the management of migraine.
Williams P; Dowson AJ; Rapoport AM; Sawyer J
Pharmacoeconomics; 2001; 19(8):819-29. PubMed ID: 11596834
[TBL] [Abstract][Full Text] [Related]
43. Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
Deleu D; Hanssens Y
Neurology; 2003 Apr; 60(7):1221-2; author reply 1221-2. PubMed ID: 12682349
[No Abstract] [Full Text] [Related]
44. Cost-effectiveness of antiepileptic drugs in migraine prophylaxis.
Adelman JU; Adelman LC; Von Seggern R
Headache; 2002; 42(10):978-83. PubMed ID: 12453029
[TBL] [Abstract][Full Text] [Related]
45. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
[TBL] [Abstract][Full Text] [Related]
46. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
47. Migraine preventive medication reduces resource utilization.
Silberstein SD; Winner PK; Chmiel JJ
Headache; 2003 Mar; 43(3):171-8. PubMed ID: 12603635
[TBL] [Abstract][Full Text] [Related]
48. Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions.
Parkinson B; Gumbie M; Cutler H; Gauld N; Mumford V; Haywood P
Value Health; 2019 Mar; 22(3):293-302. PubMed ID: 30832967
[TBL] [Abstract][Full Text] [Related]
49. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan.
Stark S; Spierings EL; McNeal S; Putnam GP; Bolden-Watson CP; O'Quinn S
Headache; 2000; 40(7):513-20. PubMed ID: 10940089
[TBL] [Abstract][Full Text] [Related]
50. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
51. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial.
Melchart D; Thormaehlen J; Hager S; Liao J; Linde K; Weidenhammer W
J Intern Med; 2003 Feb; 253(2):181-8. PubMed ID: 12542558
[TBL] [Abstract][Full Text] [Related]
52. Cost considerations of acute migraine treatment.
Adelman JU; Adelman LC; Freeman MC; Von Seggern RL; Drake J
Headache; 2004 Mar; 44(3):271-85. PubMed ID: 15012668
[TBL] [Abstract][Full Text] [Related]
53. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
Nett R; Landy S; Shackelford S; Richardson MS; Ames M; Lener M
Obstet Gynecol; 2003 Oct; 102(4):835-42. PubMed ID: 14551015
[TBL] [Abstract][Full Text] [Related]
54. A 27-year-old woman with migraine headaches.
Welch KM
JAMA; 1997 Jul 23-30; 278(4):322-8. PubMed ID: 9228439
[No Abstract] [Full Text] [Related]
55. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
[TBL] [Abstract][Full Text] [Related]
56. Sumatriptan fast-disintegrating/rapid-release tablets.
Moen MD; Keating GM
Drugs; 2006; 66(6):883-90. PubMed ID: 16706565
[TBL] [Abstract][Full Text] [Related]
57. Sumatriptan and migraine.
Akpunonu BE; Mutgi AB
Ann Emerg Med; 1996 Mar; 27(3):387-8. PubMed ID: 8599506
[No Abstract] [Full Text] [Related]
58. Sumatriptan use in patients with migraine.
Canario JR; Shenenberger DW
Mayo Clin Proc; 2002 Feb; 77(2):201. PubMed ID: 11838657
[No Abstract] [Full Text] [Related]
59. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
60. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
